Peptide Based Gastrointestinal Disorders Therapeutics Market Report

Global and China Peptide Based Gastrointestinal Disorders Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 29, 2022
  • PAGES：233
  • REPORT CODE：GMM1328144
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.

    This report elaborates on the current development of the Peptide Based Gastrointestinal Disorders Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Astellas Pharma Inc

    • Ironwood Pharmaceuticals, Inc

    • Synergy Pharmaceuticals Inc

    • Cipher Pharmaceuticals Inc

    • Allergan plc

    • NPS Pharmaceuticals, Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Teduglutide

    • Linaclotide

    • Others

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Overview

      • 1.1.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Scope and Market Segments

      • 1.1.2 Peptide Based Gastrointestinal Disorders Therapeutics Industry Characteristics

      • 1.1.3 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Teduglutide

      • 1.2.2 Linaclotide

      • 1.2.3 Others

    • 1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Industry PEST Analysis

    • 2.3 Peptide Based Gastrointestinal Disorders Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Peptide Based Gastrointestinal Disorders Therapeutics Industry

    Chapter 3 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market, by Manufacturer

    • 3.1 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market Top 3 Players

    Chapter 4 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market, by Type (2017-2028)

    • 4.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Trend, by Type

    • 4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Peptide Based Gastrointestinal Disorders Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis

    • 7.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market, by Type

    • 7.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market, by Application

    • 7.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis

    • 8.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market, by Type

    • 8.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market, by Application

    • 8.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis

    • 9.1 APAC Peptide Based Gastrointestinal Disorders Therapeutics Market, by Type

    • 9.2 APAC Peptide Based Gastrointestinal Disorders Therapeutics Market, by Application

    • 9.3 APAC Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Peptide Based Gastrointestinal Disorders Therapeutics Company Profiles

      • 11.1 Astellas Pharma Inc

        • 11.1.1 Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ironwood Pharmaceuticals, Inc

        • 11.2.1 Ironwood Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Synergy Pharmaceuticals Inc

        • 11.3.1 Synergy Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Cipher Pharmaceuticals Inc

        • 11.4.1 Cipher Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Allergan plc

        • 11.5.1 Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 NPS Pharmaceuticals, Inc

        • 11.6.1 NPS Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Product Profiles, Application and Specification

        • 11.6.3 NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Peptide Based Gastrointestinal Disorders Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Peptide Based Gastrointestinal Disorders Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Teduglutide (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Linaclotide (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Peptide Based Gastrointestinal Disorders Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Price Trend, by Type (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Type (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value, by Application (2017-2028)

    • Table China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Peptide Based Gastrointestinal Disorders Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc Product Profiles, Application and Specification

    • Table Astellas Pharma Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synergy Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synergy Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Synergy Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cipher Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cipher Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Cipher Pharmaceuticals Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan plc Product Profiles, Application and Specification

    • Table Allergan plc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NPS Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NPS Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table NPS Pharmaceuticals, Inc Peptide Based Gastrointestinal Disorders Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US